Tag: chronic myelogenous leukemia

Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial

Treatment-free remission of chronic myeloid leukemia possible after second-line nilotinib

byEvelyn Nguyenand1 others

February 20, 2018

1. Phase 2, open-label study results suggest that treatment-free remission (TFR) of chronic myeloid leukemia (CML) for ≥48 weeks can ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Few interventions improve posthospitalization follow-up for alcohol use disorder
Borderline-low hemoglobin levels linked to increased mortality
2MM: Pharma Roundup – mRNA flu vaccine debuts, RAS inhibition extends pancreatic cancer survival, and new therapies advance for dermatomyositis and Tourette syndrome

No Result

View All Result

Tag: chronic myelogenous leukemia

Treatment-free remission of chronic myeloid leukemia possible after second-line nilotinib

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits